Synexus takes part in IBM Excellence in Clinical Planning Seminar

MANCHESTER, England--(Business Wire)--
Following the recent announcement that Synexus has selected IBM Cognos`
performance management solution, Paul McCluskey, Chief Financial Officer, took
part in the Excellence in Clinical Planning Seminar in London this week where he
addressed a group of leading executives from both pharma and clinical research
organizations.

The IBM Cognos solution has been developed in conjunction with Synexus and
offers significant benefits across the clinical study lifecycle. The model
provides a single, practical platform for planning, forecasting and reporting,
in an integrated solution and allows organisations to track all stages of the
development and execution of clinical budgets and contract proposals.

Commenting on the new management solution Paul McCluskey said: "We are at the
cutting edge in the clinical trials sector and are rapidly and successfully
developing a new model that is changing the face of the industry. Adopting this
new management solution is imperative if we are to maintain the pace of our
growth."

The new performance management solution is being rolled out across Synexus
centres in the UK, Eastern Europe and South Africa in partnership with IBM
Cognos and EnterpriseBI Ltd.

Synexus background

Synexus headquartered in Manchester, England, is the world`s largest
multi-national company dedicated to the recruitment of clinical trials at its
own research centres across the globe onbehalf of its pharmaceutical, biotech
and CRO clients. Synexus has 16 research centres across the UK, Poland, Hungary,
Bulgaria, India and South Africa staffed by full time GCP trained investigators.

Synexus currently has more than twelve thousand patients enrolled in clinical
trials.

Vane Percy & Roberts for Synexus
Simon Vane Percy
Office: +44 (0) 1737 821 890/892
Mobile: +44 (0) 7710 005910
Home: +44 (0) 1883 724505
simon@vanepercy.com

Copyright Business Wire 2009